CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,020,000 | +50.2% | 38,989 | -0.1% | 0.02% | +30.8% |
| Q3 2020 | $679,000 | +4.3% | 39,019 | +0.8% | 0.01% | 0.0% |
| Q2 2020 | $651,000 | +52.8% | 38,722 | +8.1% | 0.01% | +30.0% |
| Q1 2020 | $426,000 | -1.6% | 35,824 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $433,000 | -11.8% | 35,824 | +3.1% | 0.01% | -20.0% |
| Q3 2019 | $491,000 | +26.2% | 34,743 | -0.4% | 0.01% | +25.0% |
| Q2 2019 | $389,000 | -1.3% | 34,889 | +4.1% | 0.01% | 0.0% |
| Q1 2019 | $394,000 | -9.6% | 33,528 | +2.7% | 0.01% | -27.3% |
| Q4 2018 | $436,000 | -0.7% | 32,633 | +4.3% | 0.01% | +22.2% |
| Q3 2018 | $439,000 | +1.2% | 31,292 | +13.3% | 0.01% | -10.0% |
| Q2 2018 | $434,000 | -0.2% | 27,620 | +4.5% | 0.01% | 0.0% |
| Q1 2018 | $435,000 | +10.7% | 26,440 | +21.4% | 0.01% | +11.1% |
| Q4 2017 | $393,000 | – | 21,779 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |